Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

1.

Correlation of selenium and zinc levels to antiretroviral treatment outcomes in Thai HIV-infected children without severe HIV symptoms.

Bunupuradah T, Ubolyam S, Hansudewechakul R, Kosalaraksa P, Ngampiyaskul C, Kanjanavanit S, Wongsawat J, Luesomboon W, Pinyakorn S, Kerr S, Ananworanich J, Chomtho S, van der Lugt J, Luplertlop N, Ruxrungtham K, Puthanakit T; PREDICT study group.

Eur J Clin Nutr. 2012 Aug;66(8):900-5. doi: 10.1038/ejcn.2012.57. Epub 2012 Jun 20.

PMID:
22713768
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort.

Jones CY, Tang AM, Forrester JE, Huang J, Hendricks KM, Knox TA, Spiegelman D, Semba RD, Woods MN.

J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):475-82.

PMID:
17019373
[PubMed - indexed for MEDLINE]
3.

Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy.

Puthanakit T, Kerr S, Ananworanich J, Bunupuradah T, Boonrak P, Sirisanthana V.

Pediatr Infect Dis J. 2009 Jun;28(6):488-92.

PMID:
19504731
[PubMed - indexed for MEDLINE]
4.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
[PubMed - indexed for MEDLINE]
5.

Effectiveness and safety of protease inhibitor-based regimens in HIV-infected Thai children failing first-line treatment.

Wattanutchariya N, Sirisanthana V, Oberdorfer P.

HIV Med. 2013 Apr;14(4):226-32. doi: 10.1111/j.1468-1293.2012.01061.x. Epub 2012 Oct 24.

PMID:
23094820
[PubMed - indexed for MEDLINE]
6.

Influence of highly active antiretroviral therapy on micronutrient profiles in HIV-infected patients.

Rousseau MC, Molines C, Moreau J, Delmont J.

Ann Nutr Metab. 2000;44(5-6):212-6.

PMID:
11146326
[PubMed - indexed for MEDLINE]
8.

Micronutrients and T-cell subsets: a comparison between HIV-infected and uninfected, severely malnourished Rwandan children.

Ndagije F, Baribwira C, Coulter JB.

Ann Trop Paediatr. 2007 Dec;27(4):269-75.

PMID:
18053343
[PubMed - indexed for MEDLINE]
9.

Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.

Demeter LM, Hughes MD, Coombs RW, Jackson JB, Grimes JM, Bosch RJ, Fiscus SA, Spector SA, Squires KE, Fischl MA, Hammer SM.

Ann Intern Med. 2001 Dec 4;135(11):954-64.

PMID:
11730396
[PubMed - indexed for MEDLINE]
11.

Immunologic effect of zinc supplementation in HIV-infected children receiving highly active antiretroviral therapy: a randomized, double-blind, placebo-controlled trial.

Lodha R, Shah N, Mohari N, Mukherjee A, Vajpayee M, Singh R, Singla M, Saini S, Bhatnagar S, Kabra SK.

J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):386-92. doi: 10.1097/QAI.0000000000000191.

PMID:
24798767
[PubMed - indexed for MEDLINE]
12.

Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study.

Musoke PM, Mudiope P, Barlow-Mosha LN, Ajuna P, Bagenda D, Mubiru MM, Tylleskar T, Fowler MG.

BMC Pediatr. 2010 Aug 6;10:56. doi: 10.1186/1471-2431-10-56.

PMID:
20691045
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression.

Byakwaga H, Murray JM, Petoumenos K, Kelleher AD, Law MG, Boyd MA, Emery S, Mallon PW, Cooper DA.

AIDS Res Hum Retroviruses. 2009 Jun;25(6):756-76. doi: 10.1089/aid.2008.0149.

PMID:
19500017
[PubMed - indexed for MEDLINE]
14.

Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.

Hoen B, Cooper DA, Lampe FC, Perrin L, Clumeck N, Phillips AN, Goh LE, Lindback S, Sereni D, Gazzard B, Montaner J, Stellbrink HJ, Lazzarin A, Ponscarme D, Staszewski S, Mathiesen L, Smith D, Finlayson R, Weber R, Wegmann L, Janossy G, Kinloch-de Loes S; QUEST Study Group.

Clin Infect Dis. 2007 Aug 1;45(3):381-90. Epub 2007 Jun 26.

PMID:
17599319
[PubMed - indexed for MEDLINE]
Free Article
15.

Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study.

Ananworanich J, Siangphoe U, Hill A, Cardiello P, Apateerapong W, Hirschel B, Mahanontharit A, Ubolyam S, Cooper D, Phanuphak P, Ruxrungtham K.

J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):523-9.

PMID:
16044002
[PubMed - indexed for MEDLINE]
16.

Successful paediatric HIV treatment in rural primary care in Africa.

Janssen N, Ndirangu J, Newell ML, Bland RM.

Arch Dis Child. 2010 Jun;95(6):414-21. doi: 10.1136/adc.2009.169367. Epub 2009 Oct 29.

PMID:
19880392
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

Aurpibul L, Puthanakit T, Taecharoenkul S, Sirisanthana T, Sirisanthana V.

AIDS Patient Care STDS. 2009 Dec;23(12):1067-71. doi: 10.1089/apc.2009.0093.

PMID:
19909170
[PubMed - indexed for MEDLINE]
18.

Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children.

Puthanakit T, van der Lugt J, Bunupuradah T, Ananworanich J, Gorowara M, Phasomsap C, Jupimai T, Boonrak P, Pancharoen C, Burger D, Ruxrungtham K.

J Antimicrob Chemother. 2009 Nov;64(5):1080-6. doi: 10.1093/jac/dkp322. Epub 2009 Sep 2.

PMID:
19729375
[PubMed - indexed for MEDLINE]
Free Article
19.

Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.

Srasuebkul P, Ungsedhapand C, Ruxrungtham K, Boyd MA, Phanuphak P, Cooper DA, Law MG.

HIV Med. 2007 Jan;8(1):46-54.

PMID:
17305932
[PubMed - indexed for MEDLINE]
20.

Effective treatment of patients in a deep salvage situation with "non-active HAART": experiences with the expert advice system RADATA.

Lorenzen T, Walther I, Stoehr A, Salzberger B, Plettenberg A; Radata Study Group.

Infection. 2009 Dec;37(6):528-33. doi: 10.1007/s15010-009-9022-6. Epub 2009 Oct 13.

PMID:
19826762
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk